To evaluate the effectiveness of a remote patient monitoring (RPM) diabetes program using continuous glucose monitoring (CGM) in improving glycemic outcomes among underserved patients with type 2 diabetes.
Key Findings:
RPM participants had a greater reduction in HbA1c levels (3.0 percentage points) compared to controls (2.1 percentage points, P = .004).
60% of RPM participants achieved HbA1c < 7.5% versus 36% of controls (adjusted odds ratio 2.53, P < .01).
Interpretation:
RPM paired with CGM significantly improves glycemic outcomes in urban, underserved populations with type 2 diabetes compared to standard care.
Limitations:
The study is retrospective and may not generalize to other populations.
Further studies are needed to evaluate the scalability of the RPM program.
Conclusion:
The study demonstrates the effectiveness of RPM and CGM in improving glycemic control among underserved diabetic patients, warranting further research for broader implementation.
AACE Endocrine AI
is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE®). The ideas and opinions expressed in
AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.